Evidence map›Paper›PMID 14742235›Full record

Trial reportAntimicrobial agents and chemotherapy2004

Penetration of linezolid into the anterior chamber (aqueous humor) of the human eye after intravenous administration.

E García Vázquez, J Mensa, Y López, P Díaz Couchard, D Soy, J R Fontenla, M Sarasa, X Carné, E Montull

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2007
    Article
  4. The pharmacokinetics of linezolid in the non-inflamed human eye.The British journal of ophthalmology · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

E García VázquezInstitut d'Infeccions i Immunologia, Pfizer Spain, Hospital Clínic, 08036 Barcelona, Spain. egarciav@clinic.ub.es
J Mensa
Y López
P Díaz Couchard
D Soy
J R Fontenla
M Sarasa
X Carné
E Montull
Pfizer (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We determined the linezolid concentrations in serum samples and aqueous humors (AHs) from 21 patients undergoing cataract extraction. Cataract removal was performed at various times (from 60 to 270 min) after the end of a 30-min infusion of 600 mg of linezolid. Serum samples were obtained 1 h after the end of linezolid administration to determine the maximum concentration of linezolid (C(max)); AHs and a second serum sample were taken simultaneously during the operation, and the concentrations of linezolid in AH (C(AH)) and serum (C(S)) were determined. The mean C(AH) 1 h after linezolid administration was 4.94 micro g/ml, and the mean ratio of C(AH) to C(S) (R = C(AH)/C(S)) was 0.43. All patients had a C(AH) of >2 micro g/ml, which was higher than the MIC at which 90% of Staphylococcus epidermidis strains are inhibited.

Indexed as

AcetamidesAgedAnti-Infective AgentsAqueous HumorCataract ExtractionFemaleHumansInfusions, IntravenousLinezolidMaleMicrobial Sensitivity TestsMiddle AgedOxazolidinonesStaphylococcus epidermidisAcetamidesAnti-Infective AgentsLinezolidOxazolidinones

Identifiers

PMID14742235
PMCPMC321529
OpenAlexW2172015880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.